New York City is relying significantly on over 16,000 planned residential units from office conversions to alleviate the ongoing housing shortage. Accordingly, the alarming structural emergency at the MetroLoft and David Werner Real Estate Investment conversion of the Pfizer building was taken seriously in early July, when the country's largest such conversion in the heart of Midtown threatened to collapse.
Reports of two bending columns led city officials to immediately cordon off 40th to 45th Street between First and Third Avenue. Several buildings, including a school from which approximately 400 children were evacuated, were affected.
In the weeks following the building's securing with temporary supports, the New York City Department of Buildings (DOB) initiated city-wide safety inspections at construction sites, including those associated with MetroLoft's contractor, Barone Steel Fabricators, as reported by Gothamist. A full investigation into the incident is ongoing, but the final verdict is expected to focus on the two columns and the heavy load they were supporting.
There is broad agreement in the real estate industry that the Pfizer emergency is an isolated incident. Yet, concerns that new urban regulations and associated cost overruns could now be the industry's real worry are understandable when such a prominent and comprehensive conversion, adding 19 storeys and 1,600 apartments to the existing structure, causes such disruption. Whether this is enough to unsettle the market remains to be seen; developers, real estate experts, and housing advocates are strongly hoping for the continuation of conversion projects.
Conversion projects, like any large development, are under pressure to adhere to timelines and budgets. This is exacerbated by an inflationary, volatile capital market environment and increased construction costs in New York City. Insiders argue that the bogeyman is unlikely to derail New York's conversion boom, given investor willingness and the political will behind multi-family housing construction.
New York City has by far the largest conversion market in the country. Conversion starts in the city amounted to 5 million square feet last year, representing the highest annual value in 20 years, according to Cushman & Wakefield data. As of February this year, 9.8 million square feet were planned for future conversions. The capital involved is considerable.
Significant transactions for conversion sites in 2025 included TF Cornerstone's acquisition of 135 East 57th Street for $158.5 million, as well as Vanbarton Group's acquisitions of 6 East 43rd Street for $135 million and 1011 First Avenue for $103 million.
Aaron Appel, Senior Managing Director for Capital Markets at Walker & Dunlop, stated that the Pfizer building incident, however sensational, is unlikely to affect investor appetite in the capital markets, which has remained strong and stable over the past year. He added that they are currently working on several commercial financings and see no significant impact.
However, this does not mean that lenders will not scrutinise conversion sites and development teams more closely. Laura Rapaport, founder of C-PACE lender North Bridge and a former developer, suggested that there would be more oversight, but is confident that there will be very successful conversion projects in New York and other cities. Future changes in the pace of the industry, according to Appel, would more likely be due to a renewed strength in the office market, as well as current interest rates and cap rates for multi-family assets, rather than construction fears.
The demand for conversions has therefore not changed, and the realisation of such projects is not getting easier. Appel emphasised that office properties are not easily available goods, as the office market is extraordinarily strong again. There are properties that used to be conversion opportunities but may no longer be. Therefore, demand has certainly not decreased, but implementing such projects is not easy.
The city's response to the temporary crisis remains an open question. Deputy Mayor Leila Bozorg said at a press conference in the days following the emergency that safety is central to the Mamdani administration's housing efforts, but it is still too early to draw conclusions. She pointed out that the investigation had begun and that if new findings emerged that required a re-evaluation of policy or procedures, the city would definitely undertake it.
In the meantime, Berman intends to demolish the entire extension above the columns on 42nd Street. James Whelan, President of the Real Estate Board of New York, stated that he was unaware of any delays due to the emergency or the DOB inspections at other construction projects in the city. Much of the work on conversions takes place behind walls, and progress is not checked floor by floor every time. Based on the city's investigation and the DOB's response, this could change and further increase the already high construction costs in New York City.
Jay Martin, Executive Vice President of the New York Apartment Association advocacy group, noted that everything is considerable in this environment, but this is the nature of working in a large city. When such a crisis occurs, you retreat, find a way to pay for it, and manage it. Two unique structural cost pressures already existed before the Pfizer emergency: the city's scaffolding law and the conversion levy clock already shaped the financing of these projects. New York is the only state that holds owners and contractors strictly liable for gravity-related construction injuries under the city's so-called scaffolding law.
- —The structural emergency at the Pfizer building has reignited the discussion about safety in conversion projects.
- —Experts expect increased scrutiny of conversion sites and development teams by lenders.
- —Despite the incident, investor appetite for multi-family housing in New York City remains high.
- —Future changes in the pace of conversions will be influenced more by the office market and interest rates than by construction fears.
